Edwards Lifesciences Corporation (EW)

Edwards Lifesciences Corporation is a leading global company specializing in medical innovations for heart disease patients. Founded in 1958 and headquartered in Irvine, California, the company is best known for its development of heart valve technologies and hemodynamic monitoring systems. As of 2021, Michael Mussallem serves as the CEO, a role he has held for over two decades. Edwards Lifesciences is renowned for its pioneering work in transcatheter heart valve therapies, which provide minimally invasive alternatives to open-heart surgery. Renowned for their commitment to medical advancement and patient care, they continually invest in research and development to innovate new solutions. The company's significant contributions to the medical field are reflected in its robust financial performance, with annual revenues surpassing $4 billion. Edwards Lifesciences remains dedicated to improving the quality of life for patients worldwide through its innovative, high-quality medical products.